Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levodopa for residual amblyopia in children (ATS14)
NCT00789672Phase 2Completed
- Sponsor
- Jaeb Center for Health Research
- Start
- Jan 2009
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of levodopa in amblyopia, sponsored by Jaeb Center for Health Research. Started Jan 2009; status: completed.
02
Drugs
levodopa
03
Conditions
amblyopia
Beyond the preview
Go deeper on NCT00789672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00789672.